Back

Association of pre-existing sodium-glucose cotransporter-2 inhibitor therapy with outcomes in patients presenting with cardiogenic shock: a retrospective cohort study

30 August 2026 (10:55 - 11:05)
Organised by: Logo
Congress Presentation Part of: Cardiogenic shock in acute myocardial infarction: new phenotypes and prognostic markers Cardiogenic Shock ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Michael Kunz

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Phenotype analysis reveals a “global collapse” cardiogenic shock signature despite VA-ECMO support in acute myocardial infarction – a subanalysis from ECLS-SHOCK
Doctor T. Thevathasan (Berlin, DE)
Abstract Slides
Presentation thumbnail
Prognostic value of serial SCAI staging in microaxial flow-pump-treated cardiogenic shock: impact of early hemodynamic trajectory on 30-day survival
Doctor J. Mierke (Dresden, DE)
Abstract Slides
Presentation thumbnail
Stroke-induced cardiac immune remodeling may influence cardiac outcomes in subsequent myocardial infarction
Doctor C. Liu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Hemodynamic profiles of STEMI patients at admission - prevalence and short-term outcomes of the novel PRESHOCK phenotype
Doctor S. Macherey-Meyer (Cologne, DE)
Abstract Slides
Presentation thumbnail
48-hour lactate-to-albumin ratio predicts 180-day mortality after microaxial flow pump support in cardiogenic shock
Doctor S. Kuroda (JP)
Abstract Slides

Access the full session

Session thumbnail
Cardiogenic shock in acute myocardial infarction: new phenotypes and prognostic markers
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 10:55 CET
You may be interested in
thumbnail
Congress Presentation
Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.
26 April 2024
thumbnail
Congress Presentation
Presentation characteristics, use of treatments and outcomes in patients with ischaemic vs. non-ischaemic cardiogenic shock.
28 August 2020
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction
15 March 2025
thumbnail
Congress Session
Cardiogenic shock: keep the organs running!
19 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources